Serum testosterone and cardiometabolic risk in Nigerian men with type 2 diabetes: a cross−sectional study - Takeaways - MDSpire

Serum testosterone and cardiometabolic risk in Nigerian men with type 2 diabetes: a cross−sectional study

  • By

  • Ezekiel Musa

  • Esteban Salazar-Petres

  • Glory Chinuru Musa

  • Fatima Bello

  • Adamu Girei Bakari

  • June 16, 2026

  • 0 min

Share

  • 1

    The study involved 537 adult men, including 358 with type 2 diabetes mellitus (T2DM) and 179 non-diabetic controls.

  • 2

    Men with T2DM had a significantly higher estimated 10-year ASCVD risk compared to non-diabetic controls, regardless of testosterone levels.

  • 3

    Hypogonadal T2DM men exhibited higher BMI, central obesity, and unfavorable lipid profiles compared to those with normal testosterone levels.

  • 4

    Serum testosterone was not independently associated with ASCVD risk score or individual cardiometabolic risk factors in T2DM men.

  • 5

    The findings suggest that T2DM-related metabolic risk factors are the primary drivers of cardiovascular risk, rather than testosterone levels.

Original Source(s)

Serum testosterone and cardiometabolic risk in Nigerian men with type 2 diabetes: a cross−sectional study

  • by Ezekiel Musa, Esteban Salazar-Petres, Glory Chinuru Musa, Fatima Bello, Adamu Girei Bakari

  • June 16, 2026

Related Content

Side Effects: Context Is the Diagnosis

This week's research makes one thing clear: who someone is before they get sick — their relationships, their partner's health, the back of their eye — is doing a lot of work medicine is only beginning to account for.

Sociodemographic, Health Care, and Clinical Factors Associated With Metabolic Bariatric Surgery Uptake Among

Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety